AP
Aspen Pharmacare Holdings Limited
APNHY · OTC
$9.52 -2.06% (-$0.20)
1M +3.25%
Market Cap R 68.7B
P/E Ratio 26.51x
Div. Yield 1.28%
ROE 3.13%
Bulios Fair Price
$9.85
3.5% upside
Current Price
$9.52
Undervalued Fair Value Overvalued
According to Bulios Fair Price, APNHY is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
75 /100
Cheap P/B 0.86x
P/S 2.01x
P/E 26.51x
Growth
26 /100
Declining Book val. growth 2.58%
FCF growth 25.56%
EPS growth 21.06%
Profitability
70 /100
Strong FCF margin 13.56%
Op. margin 15.48%
Gross margin 40.31%
Quality
37 /100
Average Asset turnover 0.32x
ROA 2.41%
ROIC 11.54%
Debt
89 /100
Low Net debt/EBITDA -0.06x
Int. coverage 3.51x
Debt/Equity 0.19x
Stability
37 /100
Moderate Profitable years 1
EPS volatility 241.48%
Beta 0.40x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about APNHY
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Stephen Bradley Saad
Employees
9,557
Headquarters
Durban
Upcoming events
09 OCT
Ex-Dividend
Ex-dividend date
02 NOV
Dividend Payment
Payment date
11 MAR
Earnings
Upcoming earnings report